Fontan术后双心室转换的初步经验
该研究回顾性分析2007年9月至2020年4月单中心23例Fontan循环拆除并转换为双心室循环的患者,中位年龄10.0岁。适应证包括失败Fontan生理15例(65%)和择期拆除8例(35%)。双心室转换(伴或不伴分期心室招募)使非优势心室指数化舒张末期容积、收缩末期容积和心室质量显著增加(P<.01)。总死亡5例(22%),择期转换者全部存活,失败Fontan者2年生存率72.7%(95%CI 37%-90%)。
要点
- Fontan术后双心室转换可行,可作为失败Fontan的移植替代方案。
- 择期转换者全部存活,失败Fontan者预后较差。
- 左优势型房室通道缺陷和早期手术年代是死亡预测因素。
核心结论
- Fontan术后双心室转换(一期或分期)在解剖上可行,为失败Fontan患者提供了移植以外的选择。
- 失败Fontan患者行双心室转换的预后劣于择期拆除Fontan循环者。
研究设计与样本
- 单中心回顾性分析,2007年9月至2020年4月共23例Fontan循环拆除并转换为双心室循环的患者。
- 失败Fontan生理定义为Fontan循环压力>15 mm Hg和/或存在相关并发症。
主要发现
- 23例患者中位年龄10.0(7.5-13.0)岁,失败Fontan生理15例(65%),择期拆除8例(35%)。
- 6例患者在转换前接受分期非优势心室招募手术。
- 拆除前边缘心室舒张末期容积中位z评分为-2.3(-3.3,-1.3)。
- 双心室转换后非优势心室(右14例,左9例)的指数化舒张末期容积、指数化收缩末期容积和心室质量均显著增加(P<.01)。
- 共5例(22%)死亡,其中早期死亡1例(4%);择期转换者全部存活,失败Fontan者2年生存率72.7%(95%CI 37%-90%)。
临床怎么用
- 对失败Fontan生理患者,双心室转换可作为心脏移植的替代方案,但需权衡其较差的预后。
- 择期拆除Fontan循环行双心室转换的预后较好,提示应优化手术时机。
- 左优势型房室通道缺陷患者行双心室转换死亡风险较高,需谨慎选择。
局限性
- 单中心回顾性研究,样本量小(23例)。
- 双心室转换的最佳时机仍需进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the feasibility and outcomes of biventricular conversion following takedown of Fontan circulation. METHODS: Retrospective analysis of patients who had takedown of Fontan circulation and conversion to biventricular circulation at a single center from September 2007 to April 2020. Failing Fontan physiology was defined as Fontan circulation pressure >15 mm Hg and/or the presence of associated complications. RESULTS: Biventricular conversion was performed in 23 patients at a median age of 10.0 (7.5-13.0) years. Indications included failing Fontan physiology in 15 (65%) and elective takedown in 8 (35%) patients. A subset of patients (n = 6) underwent procedures for staged recruitment of the nondominant ventricle before conversion. Median z score of end-diastolic volume of borderline ventricle before takedown was -2.3 (-3.3, -1.3). Hypoplastic left heart syndrome (P < .01) and sub-/aortic stenosis (P < .01) were more common in these patients. Biventricular conversion with or without staged ventricular recruitment led to a significant increase in indexed end-diastolic volume (P < .01), indexed end-systolic volume (P < .01), and ventricular mass (P < .01) of the nondominant ventricle (14 right, 9 left ventricle). There were 5 (22%) deaths (1 [4%] early death). All who underwent elective biventricular conversion survived, whereas 2-year survival rate for patients with a failing Fontan circulation was 72.7% (95% confidence interval, 37%-90%). The overall, 3-year reoperation-free survival was 86.7% (95% confidence interval, 56%-96%). Left dominant atrioventricular canal defect (P < .01) and early era of biventricular conversion (P = .02) were significant predictors for mortality. CONCLUSIONS: A primary as well as a staged biventricular conversion is feasible in patients who have had previous Fontan procedure. Although this provides an alternative to transplantation in patients with failing Fontan, outcomes are worse in those with failing Fontan compared with elective takedown of Fontan circulation. Optimal timing needs further evaluation.
引用
- Doulamis IP, Marathe SP, Piekarski B, et al. Biventricular conversion after Fontan completion: A preliminary experience. J Thorac Cardiovasc Surg. 2021. PMID: 34045059. doi:10.1016/j.jtcvs.2021.04.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。